The need for novel treatments to tackle with diseases affecting central nervous system (CNS) is increasing. Large pharma companies are pursuing for new ideas and projects from research organizations and micro-to-small companies. Research organizations are increasingly willing to commercialize their innovations, while small companies are devoted to expand their operations.
Research on drug targets, discovery of treatment principles and development of drug candidates is accomplished within the networks of specialists and their ecosystems. Oy Sauloner Ltd wishes to be the player in those systems.